| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |